Societal CDMO EBIT

As of the most recent data (December 2023), SCTL shows a EBIT of $-3.9M. That compares with $280K in the prior-year period — down 1506.1% year over year. That is below the Healthcare sector average of $22B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SCTL's EBIT is now $-3.9M (was $280K) — a 1506.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Societal CDMO is outperforming or lagging.

The Healthcare sector average EBIT is about $22B. Societal CDMO is at $-3.9M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how SCTL stacks up against individual peers as well.

Tracking SCTL's ebit over time shows whether Societal CDMO is scaling, shrinking, or reshaping that part of the business. The current reading is $-3.9M That compares with $280K in the prior-year period — down 1506.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Societal CDMO's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-3.9M) with ownership activity and broader fundamentals.